Argenx SE SEC filings ARGX
Argenx SE has 295 filings in SEC EDGAR's recent list, going back to Mar 1, 2017. Its latest annual report, Form 20-F, was filed on Mar 19, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Oct 22, 2026. The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-8 | Employee stock plan registration | Dec 17, 2025 | — |
| S-8 | Employee stock plan registration | Sep 27, 2023 | — |
| 424B5 | Prospectus supplement | Jul 20, 2023 | — |
| 424B5 | Prospectus supplement | Jul 17, 2023 | — |
| 424B5 | Prospectus supplement | Mar 25, 2022 | — |
| 424B5 | Prospectus supplement | Mar 22, 2022 | — |
| S-8 | Employee stock plan registration | Jul 29, 2021 | — |
| F-3ASR | Filing | Jul 29, 2021 | — |
| 424B5 | Prospectus supplement | Feb 4, 2021 | — |
| FWP | Free writing prospectus | Feb 2, 2021 | — |
| 424B5 | Prospectus supplement | Feb 1, 2021 | — |
| 424B5 | Prospectus supplement | May 29, 2020 | — |
| 424B5 | Prospectus supplement | May 26, 2020 | — |
| 424B5 | Prospectus supplement | Nov 8, 2019 | — |
| 424B5 | Prospectus supplement | Nov 6, 2019 | — |
| 424B5 | Prospectus supplement | Sep 20, 2018 | — |
| 424B5 | Prospectus supplement | Sep 17, 2018 | — |
| S-8 | Employee stock plan registration | Jun 1, 2018 | — |
| F-3ASR | Filing | Jun 1, 2018 | — |
| 424B4 | Prospectus | Dec 14, 2017 | — |
| F-1MEF | Filing | Dec 13, 2017 | — |
| F-1/A | Filing | Dec 13, 2017 | — |
| F-1/A | Filing | Dec 13, 2017 | — |
| F-1 | Registration statement (foreign issuer) | Dec 11, 2017 | — |
| 424B4 | Prospectus | May 19, 2017 | — |
| F-1MEF | Filing | May 17, 2017 | — |
| F-1/A | Filing | May 17, 2017 | — |
| FWP | Free writing prospectus | May 16, 2017 | — |
| F-1/A | Filing | May 16, 2017 | — |
| F-1/A | Filing | May 8, 2017 | — |
| F-1/A | Filing | May 4, 2017 | — |
| F-1 | Registration statement (foreign issuer) | Apr 21, 2017 | — |
Showing 32 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- ARGX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Netherlands
- Headquarters
- Zwijnaarde
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1697862
- Former names
- argenx N.V (until Apr 21, 2017)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
- Neurocrine Biosciences Inc NBIX
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.